The Incidence of Severe Diarrhea with Transdermal Fentanyl Patch: An Uncommon Event

The Incidence of Severe Diarrhea with Transdermal Fentanyl Patch: An Uncommon Event

Cancer pain is a major problem for the health care providers. One of the most important aspects of cancer pain is palliative care management. Recently, different research finding shows the efficacy of opioid analgesics such as fentanyl transdermal patch in chronic pain management. Transdermal Fent...

Full description

Bibliographic Details
Main Authors: Karim Hemati, Poupak Rahim Zadeh
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2015-06-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
analgesics cancer
chemotherapy
pain
Online Access:https://jcdr.net/articles/PDF/6024/13194_CE[Ra]_F(P)_PF1(AGAK)_PFA(AK)_PF2(PAG).pdf
id doaj-e86a7985b3e54608ad6bfb891b8f1f1a
record_format Article
spelling doaj-e86a7985b3e54608ad6bfb891b8f1f1a2020-11-25T03:24:42ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2015-06-0196UD01UD0210.7860/JCDR/2015/13194.6024The Incidence of Severe Diarrhea with Transdermal Fentanyl Patch: An Uncommon EventKarim Hemati0Poupak Rahim Zadeh1Associate Professor, Department of Anesthesia, Pain Fellowship, Ilam University of Medical Sciences, Ilam, Iran. Associate Professor, Department of Anesthesia, Pain Fellowship, Iran University of Medical Sciences, Tehran, Iran.Cancer pain is a major problem for the health care providers. One of the most important aspects of cancer pain is palliative care management. Recently, different research finding shows the efficacy of opioid analgesics such as fentanyl transdermal patch in chronic pain management. Transdermal Fentanyl patches may cause side effects such as drowsiness, dizziness, itching, life-threatening or serious breathing difficulties and diarrhea, mainly during the first 72 h of patient’s treatment initiation and any time when the drug’s dose is increased. We report three case reports of severe diarrhea without most common side effects associated with Fentanyl patches during first 72 h of patient’s treatment. https://jcdr.net/articles/PDF/6024/13194_CE[Ra]_F(P)_PF1(AGAK)_PFA(AK)_PF2(PAG).pdfanalgesics cancerchemotherapypain
collection DOAJ
language English
format Article
sources DOAJ
author Karim Hemati
Poupak Rahim Zadeh
spellingShingle Karim Hemati
Poupak Rahim Zadeh
The Incidence of Severe Diarrhea with Transdermal Fentanyl Patch: An Uncommon Event
Journal of Clinical and Diagnostic Research
analgesics cancer
chemotherapy
pain
author_facet Karim Hemati
Poupak Rahim Zadeh
author_sort Karim Hemati
title The Incidence of Severe Diarrhea with Transdermal Fentanyl Patch: An Uncommon Event
title_short The Incidence of Severe Diarrhea with Transdermal Fentanyl Patch: An Uncommon Event
title_full The Incidence of Severe Diarrhea with Transdermal Fentanyl Patch: An Uncommon Event
title_fullStr The Incidence of Severe Diarrhea with Transdermal Fentanyl Patch: An Uncommon Event
title_full_unstemmed The Incidence of Severe Diarrhea with Transdermal Fentanyl Patch: An Uncommon Event
title_sort incidence of severe diarrhea with transdermal fentanyl patch: an uncommon event
publisher JCDR Research and Publications Private Limited
series Journal of Clinical and Diagnostic Research
issn 2249-782X
0973-709X
publishDate 2015-06-01
description Cancer pain is a major problem for the health care providers. One of the most important aspects of cancer pain is palliative care management. Recently, different research finding shows the efficacy of opioid analgesics such as fentanyl transdermal patch in chronic pain management. Transdermal Fentanyl patches may cause side effects such as drowsiness, dizziness, itching, life-threatening or serious breathing difficulties and diarrhea, mainly during the first 72 h of patient’s treatment initiation and any time when the drug’s dose is increased. We report three case reports of severe diarrhea without most common side effects associated with Fentanyl patches during first 72 h of patient’s treatment.
topic analgesics cancer
chemotherapy
pain
url https://jcdr.net/articles/PDF/6024/13194_CE[Ra]_F(P)_PF1(AGAK)_PFA(AK)_PF2(PAG).pdf
work_keys_str_mv AT karimhemati theincidenceofseverediarrheawithtransdermalfentanylpatchanuncommonevent
AT poupakrahimzadeh theincidenceofseverediarrheawithtransdermalfentanylpatchanuncommonevent
AT karimhemati incidenceofseverediarrheawithtransdermalfentanylpatchanuncommonevent
AT poupakrahimzadeh incidenceofseverediarrheawithtransdermalfentanylpatchanuncommonevent
_version_ 1724600444772155392

Similar Items